In our initial study of newborn infants suffering from the respiratory distress syndrome (RDS) (Hardie, Heese, and Kench, 1965), it was found that affected infants had significantly lower serum concentrations of total proteins than normal premature infants, and that the relative and absolute concentrations of y-globulins, as determined by paper electrophoresis, were much diminished. These abnormalities were present in the cord blood and became more marked in the first 2 to 3 days.In that paper we suggested that the y-globulin deficiency could be due to either (1) defective placental transfer of y-globulins, or (2) excessive y-globulin katabolism by the affected fetus and newborn, or (3) an immune reaction taking place in the fetus and newborn involving the maternal y-globulins as either antibodies or antigens.With these possibilities in mind a more detailed and extensive investigation of the serum proteins in this condition is described.Clinical Material and Methods Subjects of the study were either normal premature infants or premature babies suffering from RDS. The mean gestational age of the normal premature infants for whom data were available (72 of the 88 in the series) was 33 9 weeks. All the RDS infants (33) were traced, and these had a mean gestational age of 35-2 weeks. The clinical criteria for diagnosis of RDS were as before (Hardie et al., 1965). They were the presence of at least two of the following features for which no other obvious cause could be found: (1) cyanosis; (2) rib recession; (3) expiratory grunting; (4) generalized oedema; and (5) a 'ground glass' opacity on x-ray of the lung fields with an air bronchogram.Where the patient presented with cyanosis and
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.